SE0000537D0 - Use of a compound for preparing a drug - Google Patents

Use of a compound for preparing a drug

Info

Publication number
SE0000537D0
SE0000537D0 SE0000537A SE0000537A SE0000537D0 SE 0000537 D0 SE0000537 D0 SE 0000537D0 SE 0000537 A SE0000537 A SE 0000537A SE 0000537 A SE0000537 A SE 0000537A SE 0000537 D0 SE0000537 D0 SE 0000537D0
Authority
SE
Sweden
Prior art keywords
group
lower alkyl
iodine
drug
compound
Prior art date
Application number
SE0000537A
Other languages
English (en)
Other versions
SE516067C2 (sv
SE0000537L (sv
Inventor
Lennart Moeller
Jan Bergman
Original Assignee
Leif J I Lundblad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leif J I Lundblad filed Critical Leif J I Lundblad
Priority to SE0000537A priority Critical patent/SE516067C2/sv
Publication of SE0000537D0 publication Critical patent/SE0000537D0/sv
Priority to AU3626601A priority patent/AU3626601A/xx
Priority to CNB018052045A priority patent/CN1192777C/zh
Priority to CA002400236A priority patent/CA2400236C/en
Priority to HU0204547A priority patent/HUP0204547A3/hu
Priority to ES01908522T priority patent/ES2222981T3/es
Priority to AU2001236266A priority patent/AU2001236266B2/en
Priority to RU2002124771/15A priority patent/RU2266117C2/ru
Priority to JP2001559467A priority patent/JP2003522792A/ja
Priority to DE60103857T priority patent/DE60103857T2/de
Priority to PCT/SE2001/000326 priority patent/WO2001060371A1/en
Priority to EP01908522A priority patent/EP1261344B1/en
Priority to AT01908522T priority patent/ATE269083T1/de
Publication of SE0000537L publication Critical patent/SE0000537L/sv
Publication of SE516067C2 publication Critical patent/SE516067C2/sv
Priority to NO20023892A priority patent/NO323783B1/no
Priority to ZA200206733A priority patent/ZA200206733B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE0000537A 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel SE516067C2 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE0000537A SE516067C2 (sv) 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel
AT01908522T ATE269083T1 (de) 2000-02-18 2001-02-16 Verwendung von indoloquinoxalinen zur behandlung der multiplen sklerose
AU2001236266A AU2001236266B2 (en) 2000-02-18 2001-02-16 Use of a compound for preparing a drug
JP2001559467A JP2003522792A (ja) 2000-02-18 2001-02-16 薬剤調製用化合物の用途
CA002400236A CA2400236C (en) 2000-02-18 2001-02-16 Use of indoloquinoxaline derivatives for preparing a drug for the treatment of multiple sclerosis
HU0204547A HUP0204547A3 (en) 2000-02-18 2001-02-16 Use of indoloquinoxaline derivatives for preparing a drug for treatment of ms
ES01908522T ES2222981T3 (es) 2000-02-18 2001-02-16 Uso de indoloquinoxalinas para el tratamiento de esclerosis multiple.
AU3626601A AU3626601A (en) 2000-02-18 2001-02-16 Use of a compound for preparing a drug
RU2002124771/15A RU2266117C2 (ru) 2000-02-18 2001-02-16 Применение соединения для получения лекарственного препарата
CNB018052045A CN1192777C (zh) 2000-02-18 2001-02-16 吲哚并喹喔啉类化合物用于制备治疗多发性硬化症的药物的用途
DE60103857T DE60103857T2 (de) 2000-02-18 2001-02-16 Verwendung von indoloquinoxalinen zur behandlung der multiplen sklerose
PCT/SE2001/000326 WO2001060371A1 (en) 2000-02-18 2001-02-16 Use of a compound for preparing a drug
EP01908522A EP1261344B1 (en) 2000-02-18 2001-02-16 Use of indoloquinoxalines for the treatment of multiple sklerosis
NO20023892A NO323783B1 (no) 2000-02-18 2002-08-16 Anvendelse av en forbindelse for fremstilling av et medikament
ZA200206733A ZA200206733B (en) 2000-02-18 2002-08-22 Use of a compound for preparing a drug.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000537A SE516067C2 (sv) 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel

Publications (3)

Publication Number Publication Date
SE0000537D0 true SE0000537D0 (sv) 2000-02-18
SE0000537L SE0000537L (sv) 2001-08-19
SE516067C2 SE516067C2 (sv) 2001-11-12

Family

ID=20278504

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000537A SE516067C2 (sv) 2000-02-18 2000-02-18 Användning av en förening för framställning av ett läkemedel

Country Status (14)

Country Link
EP (1) EP1261344B1 (sv)
JP (1) JP2003522792A (sv)
CN (1) CN1192777C (sv)
AT (1) ATE269083T1 (sv)
AU (2) AU2001236266B2 (sv)
CA (1) CA2400236C (sv)
DE (1) DE60103857T2 (sv)
ES (1) ES2222981T3 (sv)
HU (1) HUP0204547A3 (sv)
NO (1) NO323783B1 (sv)
RU (1) RU2266117C2 (sv)
SE (1) SE516067C2 (sv)
WO (1) WO2001060371A1 (sv)
ZA (1) ZA200206733B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE527639C2 (sv) * 2004-06-17 2006-05-02 Oxypharma Ab Alkylsubstituerade indolokinoxaliner
EP2128160B1 (en) 2008-04-30 2010-07-14 Universität Duisburg-Essen Indolo[2,3-b]-, Indeno[1,2-b]- and Indeno[2,1-b]pyrido[2,3-f] quinoxaline-3-carboxylic acids and esters, processes for their preparation and their use as antiviral, antibiotic and antitumor agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8600260D0 (sv) * 1986-01-21 1986-01-21 Lundblad Leif Substituerade indolokinoxaliner

Also Published As

Publication number Publication date
NO20023892D0 (no) 2002-08-16
SE516067C2 (sv) 2001-11-12
CN1192777C (zh) 2005-03-16
AU3626601A (en) 2001-08-27
RU2266117C2 (ru) 2005-12-20
DE60103857T2 (de) 2005-07-14
ZA200206733B (en) 2003-08-22
HUP0204547A2 (hu) 2003-04-28
AU2001236266B2 (en) 2005-03-17
WO2001060371A1 (en) 2001-08-23
EP1261344B1 (en) 2004-06-16
NO20023892L (no) 2002-08-16
SE0000537L (sv) 2001-08-19
NO323783B1 (no) 2007-07-09
CA2400236A1 (en) 2001-08-23
ES2222981T3 (es) 2005-02-16
ATE269083T1 (de) 2004-07-15
DE60103857D1 (de) 2004-07-22
CA2400236C (en) 2009-09-22
RU2002124771A (ru) 2004-03-10
EP1261344A1 (en) 2002-12-04
CN1404393A (zh) 2003-03-19
HUP0204547A3 (en) 2006-01-30
JP2003522792A (ja) 2003-07-29

Similar Documents

Publication Publication Date Title
HUP0002112A2 (hu) Helyettesített 3-ciano-kinolinok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
NZ518144A (en) Piperazine Compounds
NZ506574A (en) Cyclic amino derivative having a sulphinyl, sulphonyl or disulphanyl group useful in the treatment of thrombosis or embolism
HUP9802822A2 (hu) Halogén-benzimidazol-származékok, intermedierjeik, előállításuk és a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények
HUP9904703A2 (hu) Aminotiofén-karbonsav-amidok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
MY138145A (en) Thienopyrimidinediones and their use in the modulation of autoimmune disease
HUP0300743A2 (hu) Heteroarilszármazékok és alkalmazásuk gyógyszerként
HUP0101031A2 (hu) Biciklo[2.2.1]heptán-származékok és rokon vegyületek
SE8600260D0 (sv) Substituerade indolokinoxaliner
IL144170A0 (en) 4-oxo-1,4-dihydro-3-quinolinecarboamides as antiviral agents
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
MY118004A (en) Distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
TW429255B (en) Pyrazine compounds having treatment of central nervous system diseases and disorders
HUP9702393A2 (hu) bisz(2-Halogén-etil)-amino-fenil szubsztituált distamycinszármazékok, tumorellenes és vírusellenes hatóanyagok
HUP0402341A2 (hu) Szubsztituált tiazol-2-ilaminokat tartalmazó készítmények rák kezelésére
SE0000537D0 (sv) Use of a compound for preparing a drug
YU43902A (sh) Novi razgranati supstituisani amino derivati od 3-amino-1- -fenil-1h(1,2,4) triazola, postupak za njihovo dobijanje i farmaceutski preparati koji ih sadrže
MXPA04005077A (es) Derivados de benzotiazol.
TW259785B (en) Chemical compounds
MY109714A (en) Process for preparing 8-chloroquinolone derivatives
ES2103131T3 (es) Nuevos agentes de nucleosido carbociclico utiles como inhibidores selectivos de citoquinas proinflamatorias.
MY141374A (en) Water soluble camptothecin derivatives
BG102658A (en) Derivatives of condensed 2,3-benzodiazepines and their use as ampa-receptor inhibitors
SE9900677D0 (sv) Agent for use in transplantation
GB9812211D0 (en) Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents

Legal Events

Date Code Title Description
NUG Patent has lapsed